The role of Plerixafor (AMD3100) in mobilizing hematopoietic progenitor cells in patients with hematologic malignancies
Publication
, Journal Article
Reddy, GK; Crawford, J; Jain, VK
Published in: Supportive Cancer Therapy
January 1, 2006
Duke Scholars
Published In
Supportive Cancer Therapy
DOI
ISSN
1543-2912
Publication Date
January 1, 2006
Volume
3
Issue
2
Start / End Page
73 / 76
Related Subject Headings
- Oncology & Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Reddy, G. K., Crawford, J., & Jain, V. K. (2006). The role of Plerixafor (AMD3100) in mobilizing hematopoietic progenitor cells in patients with hematologic malignancies. Supportive Cancer Therapy, 3(2), 73–76. https://doi.org/10.1016/S1543-2912(13)60060-0
Reddy, G. K., J. Crawford, and V. K. Jain. “The role of Plerixafor (AMD3100) in mobilizing hematopoietic progenitor cells in patients with hematologic malignancies.” Supportive Cancer Therapy 3, no. 2 (January 1, 2006): 73–76. https://doi.org/10.1016/S1543-2912(13)60060-0.
Reddy GK, Crawford J, Jain VK. The role of Plerixafor (AMD3100) in mobilizing hematopoietic progenitor cells in patients with hematologic malignancies. Supportive Cancer Therapy. 2006 Jan 1;3(2):73–6.
Reddy, G. K., et al. “The role of Plerixafor (AMD3100) in mobilizing hematopoietic progenitor cells in patients with hematologic malignancies.” Supportive Cancer Therapy, vol. 3, no. 2, Jan. 2006, pp. 73–76. Scopus, doi:10.1016/S1543-2912(13)60060-0.
Reddy GK, Crawford J, Jain VK. The role of Plerixafor (AMD3100) in mobilizing hematopoietic progenitor cells in patients with hematologic malignancies. Supportive Cancer Therapy. 2006 Jan 1;3(2):73–76.
Published In
Supportive Cancer Therapy
DOI
ISSN
1543-2912
Publication Date
January 1, 2006
Volume
3
Issue
2
Start / End Page
73 / 76
Related Subject Headings
- Oncology & Carcinogenesis